Identification of ageing-associated naturally occurring peptides in human urine

Oncotarget

Volumn 6, Issue 33, 2015, Pages 34106-34117

  Nkuipou Kenfack, Esther ^a,b   Bhat, Akshay ^a,c   Klein, Julie ^d,e   Jankowski, Vera ^f   Mullen, William ^g   Vlahou, Antonia ^h,i   Dakna, Mohammed ^a   Koeck, Thomas ^a   Schanstra, Joost P ^e,f   Zürbig, Petra ^a   Rudolph, Karl L ^j   Schumacher, Björn ^k   Pich, Andreas ^b   Mischak, Harald ^a,g  

^a MOSAIQUES DIAGNOSTICS GMBH   (Germany)

^b HANNOVER MEDICAL SCHOOL   (Germany)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^d INSERM   (France)

^e UNIVERSITÉ PAUL SABATIER   (France)

^f UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

^g UNIVERSITY OF GLASGOW   (United Kingdom)

^h Academy of Athens Biomedical Research Foundation   (Greece)

ⁱ UNIVERSITY OF PLYMOUTH   (United Kingdom)

^j FRITZ LIPMANN INSTITUTE   (Germany)

^k UNIVERSITY OF COLOGNE   (Germany)

more..

Author keywords

Ageing; Collagen; Gerotarget; Peptidomics; Proteases; Systems biology; Urine

Indexed keywords

BETA 2 MICROGLOBULIN; CATHEPSIN; COLLAGEN; COLLAGEN TYPE 4; FIBRINOGEN; MATRIX METALLOPROTEINASE; PEPTIDE DERIVATIVE; PROTEINASE; SOMATOMEDIN BINDING PROTEIN; TAMM HORSFALL GLYCOPROTEIN; TOLL LIKE RECEPTOR; PEPTIDE; PROTEOME;

ADULT; AGE DISTRIBUTION; AGED; AGING; ARTICLE; CARDIOVASCULAR DISEASE; COHORT ANALYSIS; COLLAGEN METABOLISM; COMPUTER MODEL; CONTROLLED STUDY; CORRELATION FUNCTION; DIABETES MELLITUS; ENDOSOME; FEMALE; HUMAN; KIDNEY DISEASE; MAJOR CLINICAL STUDY; MALE; MOLECULAR BIOLOGY; MOLECULAR MECHANICS; PATIENT INFORMATION; PEPTIDE ANALYSIS; PROTEIN DEGRADATION; PROTEIN TRANSPORT; URINARY EXCRETION; VERY ELDERLY; METABOLISM; MIDDLE AGED; PHYSIOLOGY; URINE; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; AGING; CARDIOVASCULAR DISEASES; COLLAGEN; DIABETES MELLITUS; FEMALE; FIBRINOGEN; HUMANS; KIDNEY DISEASES; MALE; MIDDLE AGED; PEPTIDES; PROTEOME; UROMODULIN; YOUNG ADULT;

EID: 84946594740     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.5896     Document Type: Article

References (45)

1. Lopez-Otin C, Blasco MA, Partridge L, Serrano M and Kroemer G. The hallmarks of aging. Cell. 2013;153:1194-1217.
2. Nkuipou-Kenfack E, Koeck T, Mischak H, Pich A, Schanstra JP, Zürbig P and Schumacher B. Proteome analysis in the assessment of ageing. Ageing Res Rev. 2014;18C:74-85.
3. Zürbig P, Decramer S, Dakna M, Jantos J, Good DM, Coon JJ, Bandin F, Mischak H, Bascands JL and Schanstra JP. The human urinary proteome reveals high similarity between kidney aging and chronic kidney disease. Proteomics. 2009;9:2108-2117.
4. Stalmach A, Albalat A, Mullen W and Mischak H. Recent advances in capillary electrophoresis coupled to mass spectrometry for clinical proteomic applications. Electrophoresis. 2013;34:1452-1464.
5. Klein J, Eales J, Zurbig P, Vlahou A, Mischak H and Stevens R. Proteasix: A tool for automated and large-scale prediction of proteases involved in naturally occurring peptide generation. Proteomics. 2013;13:1077-1082.
6. Mouw JK, Ou G and Weaver VM. Extracellular matrix assembly: a multiscale deconstruction. Nat Rev Mol Cell Biol. 2014;15:771-785.
7. Baroni ER, Biondo-Simoes ML, Auersvald A, Auersvald LA, Montemor Netto MR, Ortolan MC and Kohler JN. Influence of aging on the quality of the skin of white women: the role of collagen. Acta Cir Bras. 2012;27:736-740.
8. Bonnans C, Chou J and Werb Z. Remodelling the extracellular matrix in development and disease. Nat Rev Mol Cell Biol. 2014;15:786-801.
9. Wilusz RE, Zauscher S and Guilak F. Micromechanical mapping of early osteoarthritic changes in the pericellular matrix of human articular cartilage. Osteoarthritis Cartilage. 2013;21:1895-1903.
10. Ishijima M, Kaneko H and Kaneko K. The evolving role of biomarkers for osteoarthritis. Ther Adv Musculoskelet Dis. 2014;6:144-153.
11. Liu X, Wu H, Byrne M, Krane S and Jaenisch R. Type III collagen is crucial for collagen I fibrillogenesis and for normal cardiovascular development. Proc Natl Acad Sci U S A. 1997;94:1852-1856.
12. Stadtman ER, Van RH, Richardson A, Wehr NB and Levine RL. Methionine oxidation and aging. Biochim Biophys Acta. 2005;1703:135-140.
13. Hudson BG, Tryggvason K, Sundaramoorthy M and Neilson EG. Alport's syndrome, Goodpasture's syndrome, and type IV collagen. N Engl J Med. 2003;348:2543-2556.
14. Araki S, Haneda M, Koya D, Isshiki K, Kume S, Sugimoto T, Kawai H, Nishio Y, Kashiwagi A, Uzu T and Maegawa H. Association between urinary type IV collagen level and deterioration of renal function in type 2 diabetic patients without overt proteinuria. Diabetes Care. 2010;33:1805-1810.
15. Docherty NG and Godson C. Fibrinogen as a damageassociated mitogenic signal for the renal fibroblast. Kidney Int. 2011;80:1014-1016.
16. Scolari F, Izzi C and Ghiggeri GM. Uromodulin: from monogenic to multifactorial diseases. Nephrol Dial Transplant. 2015;30:1250-1256.
17. Chiou SJ and Chen CH. Decipher beta2-microglobulin: gain-or loss-of-function (a mini-review). Med Sci Monit Basic Res. 2013;19:271-273.
18. Astor BC, Shafi T, Hoogeveen RC, Matsushita K, Ballantyne CM, Inker LA and Coresh J. Novel markers of kidney function as predictors of ESRD, cardiovascular disease, and mortality in the general population. Am J Kidney Dis. 2012;59:653-662.
19. Kals J, Zagura M, Serg M, Kampus P, Zilmer K, Unt E, Lieberg J, Eha J, Peetsalu A and Zilmer M. beta2-microglobulin, a novel biomarker of peripheral arterial disease, independently predicts aortic stiffness in these patients. Scand J Clin Lab Invest. 2011;71:257-263.
20. Schanstra JP, Zurbig P, Alkhalaf A, Argiles A, Bakker SJ, Beige J, Bilo HJ, Chatzikyrkou C, Dakna M, Dawson J, Delles C, Haller H, Haubitz M, et al. Diagnosis and Prediction of CKD Progression by Assessment of Urinary Peptides. J Am Soc Nephrol. 2015;26:1999-2010.
21. Zhou XJ, Rakheja D, Yu X, Saxena R, Vaziri ND and Silva FG. The aging kidney. Kidney Int. 2008;74:710-720.
22. Pejchinovski M, Hrnjez D, Ramirez-Torres A, Bitsika V, Mermelekas G, Vlahou A, Zürbig P, Mischak H, Metzger J and Koeck T. Capillary zone electrophoresis on-line coupled to mass spectrometry: a perspective application for clinical proteomics. Proteomics Clin Appl. 2015;9:453-468.
23. Anderson S, Halter JB, Hazzard WR, Himmelfarb J, Horne FM, Kaysen GA, Kusek JW, Nayfield SG, Schmader K, Tian Y, Ashworth JR, Clayton CP, Parker RP, et al. Prediction, progression, and outcomes of chronic kidney disease in older adults. J Am Soc Nephrol. 2009;20:1199-1209.
24. Biernacka A and Frangogiannis NG. Aging and Cardiac Fibrosis. Aging Dis. 2011;2:158-173.
25. Ma J, Chadban SJ, Zhao CY, Chen X, Kwan T, Panchapakesan U, Pollock CA and Wu H. TLR4 activation promotes podocyte injury and interstitial fibrosis in diabetic nephropathy. PLoS ONE. 2014;9:e97985.
26. Garcia-Cattaneo A, Gobert FX, Muller M, Toscano F, Flores M, Lescure A, Del Nery E and Benaroch P. Cleavage of Toll-like receptor 3 by cathepsins B and H is essential for signaling. Proc Natl Acad Sci U S A. 2012;109:9053-9058.
27. Turk B and Turk V. Lysosomes as "suicide bags" in cell death: myth or reality? J Biol Chem. 2009;284:21783-21787.
28. Kim KS, Seu YB, Baek SH, Kim MJ, Kim KJ, Kim JH and Kim JR. Induction of cellular senescence by insulin-like growth factor binding protein-5 through a p53-dependent mechanism. Mol Biol Cell. 2007;18:4543-4552.
29. Gong Z, Kennedy O, Sun H, Wu Y, Williams GA, Klein L, Cardoso L, Matheny RW, Hubbard GB, Ikeno Y, Farrar RP, Schaffler MB, Adamo ML, et al. Reductions in serum IGF-1 during aging impair health span. Aging Cell. 2014;13:408-418.
30. Booth BA, Boes M, Dake BL, Knudtson KL and Bar RS. IGFBP-3 binding to endothelial cells inhibits plasmin and thrombin proteolysis. Am J Physiol Endocrinol Metab. 2002;282:E52-E58.
31. Ivarsen P, Chen JW, Tietze I, Christiansen JS, Flyvbjerg A and Frystyk J. Marked reductions in bioactive insulin-like growth factor I (IGF-I) during hemodialysis. Growth Horm IGF Res. 2010;20:156-161.
32. Higashi Y, Sukhanov S, Anwar A, Shai SY and Delafontaine P. Aging, atherosclerosis, and IGF-1. J Gerontol A Biol Sci Med Sci. 2012;67:626-639.
33. Siwy J, Mullen W, Golovko I, Franke J and Zürbig P. Human urinary peptide database for multiple disease biomarker discovery. Proteomics Clin Appl. 2011;5:367-374.
34. Mischak H and Schanstra JP. CE-MS in biomarker discovery, validation, and clinical application. Proteomics Clin Appl. 2011;5:9-23.
35. Arab S, Gramolini AO, Ping P, Kislinger T, Stanley B, van Eyk J, Ouzounian M, MacLennan DH, Emili A and Liu PP. Cardiovascular proteomics: tools to develop novel biomarkers and potential applications. J Am Coll Cardiol. 2006;48:1733-1741.
36. Jantos-Siwy J, Schiffer E, Brand K, Schumann G, Rossing K, Delles C, Mischak H and Metzger J. Quantitative Urinary Proteome Analysis for Biomarker Evaluation in Chronic Kidney Disease. J Proteome Res. 2009;8:268-281.
37. Gu YM, Thijs L, Liu YP, Zhang Z, Jacobs L, Koeck T, Zürbig P, Lichtinghagen R, Brand K, Kuznetsova T, Olivi L, Verhamme P, Delles C, et al. The urinary proteome as correlate and predictor of renal function in a population study. Nephrol Dial Transplant. 2014;29:2260-2268.
38. Kuznetsova T, Mischak H, Mullen W and Staessen JA. Urinary proteome analysis in hypertensive patients with left ventricular diastolic dysfunction. Eur Heart J. 2012;33:2342-2350.
39. Zürbig P, Renfrow M.B., Schiffer E, Novak J, Walden M, Wittke S, Just I, Pelzing M, Neusüss C, Theodorescu D, Root KE, Ross MM and Mischak H. Biomarker discovery by CE-MS enables sequence analysis via MS/MS with platform-independent separation. Electrophoresis. 2006;27:2111-2125.
40. Benjamini Y and Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J Royal Stat Soc B (Methodological). 1995;57:125-133.
41. Benjamini Y and Yekutieli D. The control of the false discovery rate under dependency. Ann Stat. 2001;29:1165-1188.
42. Bindea G, Mlecnik B, Hackl H, Charoentong P, Tosolini M, Kirilovsky A, Fridman WH, Pagès F, Trajanoski Z and Galon J. ClueGO: a Cytoscape plug-in to decipher functionally grouped gene ontology and pathway annotation networks. Bioinformatics. 2009;25:1091-1093.
43. Bindea G, Galon J and Mlecnik B. CluePedia Cytoscape plugin: pathway insights using integrated experimental and in silico data. Bioinformatics. 2013;29:661-663.
44. Haw R, Hermjakob H, D'Eustachio P and Stein L. Reactome pathway analysis to enrich biological discovery in proteomics data sets. Proteomics. 2011;11:3598-3613.
45. Saito M, Kimoto M, Araki T, Shimada Y, Fujii R, Oofusa K, Hide M, Usui T, Yoshizato K. Proteome analysis of gelatin-bound urinary proteins from patients with bladder cancers. Eur Urol. 2005;48:865-871.